Logo
Emergency Pack Dissolving Kit – Including 2 x Epi Pen

Emergency Pack Dissolving Kit – Including 2 x Epi Pen

AestheticsRx

Emergency medical kit
  • Kit contents are composed of prescription Only medicines and medical devices that are sourced through a GPhC Registered UK pharmacy (AestheticsRX Pharma Ltd).
  • Individual medicines within the kit (e.g. EpiPen, hyaluronidase, aspirin, cetirizine, timolol) are licensed products regulated by the MHRA in the UK.
  • The kit composition reflects commonly recommended emergency medicines and consumables for aesthetic practice as outlined in UK aesthetic complication guidance (e.g. ACE Group Style protocols).
  • Use of the kit is restricted to qualified healthcare professionals in line with UK medicines legislation and professional standards.
Aesthetic complications emergency and dissolving kit with EpiPen

Description

The Emergency Pack Dissolving Kit – Including 2 x EpiPen is a practitioner-ready emergency and dissolving kit specifically designed for aesthetic clinics and healthcare professionals performing injectable treatments. It brings together two EpiPen 300 mcg adrenaline auto-injectors with hyaluronidase, aspirin, oral antihistamines, timolol eye drops, normal saline, eye wash solutions, syringes and needles, providing rapid access to essential medicines and consumables required to manage rare but serious complications such as anaphylaxis, vascular occlusion, filler-related vascular compromise and other adverse reactions. Compact, organised and ready for immediate use, the kit is structured to support quick, decisive intervention, streamline emergency workflows and underpin robust patient-safety and risk-management protocols in advanced aesthetic practice.

Bnefits

  • Provides an all-in-one, practitioner-ready emergency kit aligned with recognised aesthetic complications guidance for managing serious events such as anaphylaxis and vascular occlusion.
  • Includes 2 x EpiPen 300 mcg adrenaline auto-injectors for rapid, first-line treatment of severe allergic reactions with redundancy for a second dose if required.
  • Contains 4 x hyaluronidase 1500u ampoules to facilitate dissolving of hyaluronic acid filler in cases of vascular compromise, overfilling, migration or nodules.
  • Supplies aspirin, cetirizine, timolol eye drops and saline to support management of vascular events and ocular-related filler complications in line with accepted protocols.
  • Provides a full set of Luer Lock syringes and colour-coded needles (blue, yellow, grey) for precise, controlled administration of emergency medicines and dissolving agents.
  • Organises all critical items in one compact kit to reduce delay and confusion in high-pressure emergency scenarios.
  • Supports clinic compliance with best-practice recommendations for having an appropriate emergency kit immediately available when providing injectable aesthetic treatments.
  • Enhances patient confidence and clinic professionalism by demonstrating preparedness for rare but serious complications.
  • Suitable for use only by qualified prescribers and healthcare professionals trained in aesthetic emergency management.

Indications

  • Emergency preparedness in aesthetic clinics performing dermal filler and injectable procedures.
  • Immediate on-site management of suspected anaphylaxis or severe allergic reactions during or after aesthetic treatments.
  • Rapid intervention in suspected vascular occlusion or vascular compromise following hyaluronic acid filler injections.
  • Management support for filler-related complications such as delayed swelling, nodules, Tyndall effect or misplacement where hyaluronidase use is clinically indicated.
  • Provision of essential tools and medicines to stabilise patients while awaiting emergency medical services in critical situations.
  • Assisting trained clinicians in delivering evidence-aligned complication management according to national or ACE Group-style guidelines.

Composition

  • 2 x EpiPen 300 mcg adrenaline (epinephrine) auto-injectors.
  • 4 x Hyaluronidase 1500 units ampoules (for reconstitution and use in dissolving hyaluronic acid fillers, as clinically indicated).
  • 28 x Aspirin 75 mg tablets.
  • 30 x Cetirizine 10 mg tablets.
  • 1 x Timolol 0.5% eye drops.
  • 3 x Blue needles (commonly 23G).
  • 3 x Yellow needles (commonly 30G).
  • 3 x Grey needles (commonly 27G).
  • 3 x 1 ml Luer Lock syringes.
  • 3 x 3 ml Luer Lock syringes.
  • 3 x 10 ml Luer Lock syringes.
  • 4 x Normal Saline 0.9% (small-volume ampoules or vials for injection/reconstitution).
  • 2 x Saline eye washes.
  • Kit container/pouch or packaging (as supplied by AestheticsRX Pharma) to organise and protect contents.

Formulation

  • Kit comprising multiple prescription-only medicines and Class I/II medical devices packaged together for emergency use in aesthetic practice.
  • EpiPen: prefilled, single-use, spring-loaded auto-injector containing 300 mcg epinephrine solution for intramuscular injection into the outer thigh.
  • Hyaluronidase 1500u ampoules: powder or lyophilised enzyme for reconstitution with suitable diluent (e.g. 0.9% sodium chloride) prior to injection.
  • Aspirin 75 mg: low-dose oral tablets commonly used as antiplatelet therapy where indicated.
  • Cetirizine 10 mg: oral non-sedating H1 antihistamine tablets.
  • Timolol 0.5% eye drops: topical beta-blocker ophthalmic solution used in emergency protocols relating to visual complications and raised intraocular pressure, as per specialist guidance.
  • Normal Saline 0.9%: isotonic sodium chloride solution ampoules for injection, dilution and flushing.
  • Saline eye washes: sterile sodium chloride solutions for ocular irrigation.
  • Assorted needles and Luer Lock syringes: single-use devices for accurate administration of emergency medications and dissolving agents.

Packaging

  • Supplied as a complete emergency pack by AestheticsRX Pharma, containing all listed medicines and consumables.
  • Each medicine (EpiPen, hyaluronidase, aspirin, cetirizine, timolol, saline, eye wash) retains its original manufacturer’s packaging and patient information leaflets where applicable.
  • Syringes and needles individually sterile-wrapped in single-use blister or peel packs.
  • All components assembled into a compact, clinic-ready kit (box or pouch) designed for rapid identification and access in emergency situations.
  • External labelling identifies the product as an Emergency Pack Dissolving Kit including 2 x EpiPen, with relevant prescription-only notices where required.

Usage

  • For use only by qualified, prescribing healthcare professionals or practitioners operating under appropriate clinical governance and trained in aesthetic emergency management.
  • Store the emergency kit in a clearly marked, easily accessible location within each treatment area; ensure all staff know its location and contents.
  • Follow current national, local and professional guidelines (e.g. ACE Group-style guidance) for recognition and management of anaphylaxis, vascular occlusion and other aesthetic complications.
  • In suspected anaphylaxis, administer EpiPen according to current anaphylaxis protocols and the device’s official instructions, call emergency medical services immediately and monitor the patient continuously.
  • Use hyaluronidase according to established filler complication protocols and within a valid prescription, reconstituting and dosing appropriately for the indication (e.g. vascular occlusion, nodules, Tyndall effect) and injection site.
  • Administer aspirin, cetirizine, timolol eye drops and saline only when clinically indicated, following appropriate guidelines and contraindication checks.
  • Use syringes and needles in an aseptic manner; do not reuse any single-use device.
  • Document all emergency interventions, including medicine batch numbers, dosages and times, in the patient record and, where appropriate, report serious complications according to local governance and pharmacovigilance requirements.
  • Regularly train and refresh the clinical team in the location and correct use of all kit components and run simulated emergency drills to maintain competence.

Contraindications

  • Use of any medicine in the kit is contraindicated in patients with known hypersensitivity to that specific active substance or its excipients (e.g. epinephrine, hyaluronidase, aspirin, cetirizine, timolol).
  • Aspirin is generally contraindicated in patients with aspirin or NSAID allergy, active peptic ulcer disease, bleeding disorders or in certain age groups/conditions as per medical guidance.
  • Cetirizine and other antihistamines should be avoided or used with caution in patients with known allergy or specific contraindications outlined in the product literature.
  • Timolol eye drops are contraindicated in patients with certain cardiac or respiratory conditions (e.g. significant bronchial asthma, severe COPD, certain heart blocks), unless specifically assessed and prescribed by an appropriate specialist.
  • All medicines must be used within their licensed indications and with caution in pregnancy, breastfeeding or in patients with significant comorbidities, following prescriber judgement.
  • The kit should not be used by untrained or non-qualified individuals; inappropriate use of emergency medicines carries significant risk.

Adverse Effects

  • EpiPen (epinephrine) may cause palpitations, tachycardia, anxiety, tremor, headache, dizziness, pallor, sweating, nausea, vomiting and, rarely, serious cardiovascular events (e.g. arrhythmias, angina, hypertensive crisis), particularly in patients with underlying cardiac disease.
  • Hyaluronidase injections may lead to local pain, swelling, bruising, erythema or, rarely, allergic reactions; excessive doses or incorrect placement may alter desired filler results beyond the target area.
  • Aspirin can cause gastrointestinal irritation, dyspepsia, bleeding, bronchospasm in aspirin-sensitive individuals and allergic reactions.
  • Cetirizine may cause drowsiness, dry mouth, headache or gastrointestinal symptoms in some patients.
  • Timolol eye drops may produce local irritation, burning, redness, blurred vision or systemic beta-blocker effects (e.g. bradycardia, hypotension, bronchospasm) if systemically absorbed.
  • Normal saline and saline eye wash are generally well tolerated but may cause transient discomfort or irritation when used for flushing.
  • Needle and syringe use carries the usual risks of local trauma, bleeding, infection or vascular injury if not used correctly.
  • Serious or unexpected adverse effects should be managed according to standard medical practice and reported via appropriate pharmacovigilance systems.

Storage Conditions

  • Store the kit and its contents at the temperature ranges specified in each individual product’s summary of product characteristics; typically in a cool, dry place away from direct sunlight and sources of heat.
  • Do not refrigerate or freeze EpiPen auto-injectors unless specifically indicated; avoid exposing them to extreme temperatures (e.g. hot cars, freezers).
  • Keep all medicines in their original packaging until use to protect from light and contamination and to retain batch and expiry information.
  • Regularly check expiry dates and solution appearance (e.g. epinephrine should remain clear and colourless; discard if discoloured or containing particulates).
  • Store the kit in a clearly marked, easily accessible location, out of reach of unauthorised persons and children.
  • Ensure sharps and unused/expired medicines are disposed of via approved clinical waste and sharps disposal routes in accordance with local regulations.

Duration

The kit is intended for immediate, short-term use during acute emergencies rather than continuous treatment. Individual medicines (e.g. EpiPen, hyaluronidase, aspirin, cetirizine, timolol) are administered episodically according to emergency protocols; the kit should be replenished promptly after any use and maintained in-date on an ongoing basis for as long as injectable aesthetic treatments are performed.

Onset

Onset of effect depends on the medicine used: epinephrine delivered via EpiPen typically acts within minutes to counteract anaphylaxis; hyaluronidase begins to break down hyaluronic acid filler shortly after injection; aspirin, cetirizine and timolol achieve their pharmacological effects over minutes to hours according to standard clinical expectations. All use should follow current evidence-based emergency guidelines.

Browse more Emergency medical kit

Top Treatments

Top Cities in the UK